ArrayExpress Uploader03308iMCL (indolent mantle cell lymphoma)iMCL (indolent mantle cell lymphoma)iMCL (indolent mantle cell lymphoma)iMCL (indolent mantle cell lymphoma)iMCL (indolent mantle cell lymphoma)iMCL (indolent mantle cell lymphoma)iMCL (indolent mantle cell lymphoma)cMCL (conventional mantle cell lymphoma)cMCL (conventional mantle cell lymphoma)cMCL (conventional mantle cell lymphoma)cMCL (conventional mantle cell lymphoma)cMCL (conventional mantle cell lymphoma)cMCL (conventional mantle cell lymphoma)cMCL (conventional mantle cell lymphoma)cMCL (conventional mantle cell lymphoma)cMCL (conventional mantle cell lymphoma)cMCL (conventional mantle cell lymphoma)cMCL (conventional mantle cell lymphoma)cMCL (conventional mantle cell lymphoma)cMCL (conventional mantle cell lymphoma)cMCL (conventional mantle cell lymphoma)cMCL (conventional mantle cell lymphoma)HCL (Hairy Cell Leukemia)-variantHCL (Hairy Cell Leukemia)HCL (Hairy Cell Leukemia)HCL (Hairy Cell Leukemia)HCL (Hairy Cell Leukemia)-variantSMLZ (Splenic Marginal Zone Lymphoma)SMLZ (Splenic Marginal Zone Lymphoma)SMLZ (Splenic Marginal Zone Lymphoma)SMLZ (Splenic Marginal Zone Lymphoma)CLL (Chronic Lymphocytic Leukemia)CLL (Chronic Lymphocytic Leukemia)CLL (Chronic Lymphocytic Leukemia)CLL (Chronic Lymphocytic Leukemia)CLL (Chronic Lymphocytic Leukemia)CLL (Chronic Lymphocytic Leukemia)CLL (Chronic Lymphocytic Leukemia)CLL (Chronic Lymphocytic Leukemia)CLL (Chronic Lymphocytic Leukemia)CLL (Chronic Lymphocytic Leukemia)CLL (Chronic Lymphocytic Leukemia)CLL (Chronic Lymphocytic Leukemia)CLL (Chronic Lymphocytic Leukemia)CLL (Chronic Lymphocytic Leukemia)CLL (Chronic Lymphocytic Leukemia)CLL (Chronic Lymphocytic Leukemia)CLL (Chronic Lymphocytic Leukemia)LF (follicular lymphoma)LF (follicular lymphoma)LF (follicular lymphoma)LF (follicular lymphoma)LF (follicular lymphoma)LF (follicular lymphoma)LF (follicular lymphoma)arrayexpress_sid4Mantle cell lymphoma (MCL) is an aggressive neoplasm with poor outcome. However, some patients have an indolent disease (iMCL) and may...20124476E-GEOD-16455/profile/8773/arrayexpressuploader155cellclldiseaselymphomamantle cell lymphomaDec.12, 2014Falsetranscription-profiling-by-array-of-human-indolentE-GEOD-16455_A-AFFY-44Transcription profiling by array of human indolent mantle cell lymphomaSep.12, 2014Mantle cell lymphoma (MCL) is an aggressive neoplasm with poor outcome. However, some patients have an indolent disease (iMCL) and may not require intensive treatment at initial diagnosis. Diagnostic criteria to recognize these patients are not available. We hypothesized that the analysis of the genetic and expression features of the tumors may help to identify patients with an indolent clinical evolution and provide biomarkers that could be used in the clinical setting. Seven patients with an iMCL that did not require chemotherapy for more than 2 years were compared to 15 conventional MCL (cMCL) that needed systemic therapy at diagnosis. MCL were compared with other leukemic lymphoid neoplasms including 17 CLL, 7FL, HCL and 2HCLv.http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-16455humanhttp://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-16455/samples/